Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simpl'HIV
NCT03160105Phase 4Completed
- Sponsor
- Alexandra Calmy
- Start
- May 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dolutegravir, emtricitabine in human immunodeficiency virus infection (HIV), sponsored by Alexandra Calmy. Started May 2017; status: completed.
02
Drugs
dolutegraviremtricitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03160105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03160105.